-
Mashup Score: 0Latest updates on CAR-T therapy for lymphoma - 3 year(s) ago
At present, four types of chimeric antigen receptor T-cell (CAR-T) therapy are FDA approved for specific types of lymphoma: for…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Latest updates on CAR-T therapy for lymphoma - 3 year(s) ago
At present, four types of chimeric antigen receptor T-cell (CAR-T) therapy are FDA approved for specific types of lymphoma: for…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#VJSounds | Latest updates on CAR-T therapy for #Lymphoma With leading experts including Caron Jacobson, Stephen Schuster & Jeremy Abramson 👨⚕️👩⚕️ 🎧 Listen now: https://t.co/5nZsU9uH3A @VJHemOnc #iwCART21 #LYMsm #CART #CaxTx
-
-
Mashup Score: 0CAR-T & Cellular Therapy Archives | VJHemOnc - 3 year(s) ago
Skip to contentVisit Welcome to CAR-T & Cellular Therapy Focus, where you can explore the latest updates in this field by haematological disease and therapy type, showcasing expert interviews and discussions, podcasts and e-learning.CAR-T and other cellular therapies are at the frontier of hematological malignancy research, offering the potential for paradigm-changing new treatments. Although…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🚨The final day of the 3rd #iwCART21 Virtual Workshop has begun! More updates on #CARTcell here 👉https://t.co/esOScnNy46👈 @VJHemOnc #CellTherapy #CARTcell #HemOnc #Lymsm #MMsm #Leusm https://t.co/6aC4BUntzg
-
-
Mashup Score: 13CAR-T & Cellular Therapy Archives | VJHemOnc - 3 year(s) ago
Skip to contentVisit Welcome to CAR-T & Cellular Therapy Focus, where you can explore the latest updates in this field by haematological disease and therapy type, showcasing expert interviews and discussions, podcasts and e-learning.CAR-T and other cellular therapies are at the frontier of hematological malignancy research, offering the potential for paradigm-changing new treatments. Although…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#iwCART21: Jianxiang Wang of the Peking Union Medical College gives an overview of CAR-T in #MultipleMyeloma in China 👨⚕️ More #CARTcell updates 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #CART #Immunotherapy #tcellrx #CellularTherapy #HemOnc #LEUsm #LYMsm #OncoAlert #MMsm #Myeloma https://t.co/WLXySbRLxX
-
#iwCART21: @CohenAd_MMdoc of @PennCancer discusses BCMA and non-BCMA targets for #MultipleMyeloma therapy 👨⚕️ 📣 More #CARTcell updates 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #CART #Immunotherapy #tcellrx #CellularTherapy #HemOnc #LEUsm #LYMsm #OncoAlert #MMsm #Myeloma https://t.co/YK8uZkxQ12
-
#iwCART21: Sham Mailankody of @sloan_kettering outlines the role of allo-CAR-T for #MultipleMyeloma 👨⚕️ 📣 More #CARTcell updates 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #CART #Immunotherapy #tcellrx #CellularTherapy #HemOnc #LEUsm #LYMsm #OncoAlert #MMsm #Myeloma https://t.co/gXXMeumrZV
-
-
Mashup Score: 0CAR-T & Cellular Therapy Archives | VJHemOnc - 3 year(s) ago
Skip to contentVisit Welcome to CAR-T & Cellular Therapy Focus, where you can explore the latest updates in this field by haematological disease and therapy type, showcasing expert interviews and discussions, podcasts and e-learning.CAR-T and other cellular therapies are at the frontier of hematological malignancy research, offering the potential for paradigm-changing new treatments. Although…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
It's day 2 of #iwCART21 and @ninashah33 of @UCSF is talking on BCMA CAR-Ts for #MultipleMyeloma 👩⚕️ 📣 More #CARTcell updates 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #CART #Immunotherapy #tcellrx #CellularTherapy #HemOnc #LEUsm #LYMsm #OncoAlert #MMsm #Myeloma https://t.co/rOOKDad7vK
-
-
Mashup Score: 22CAR-T & Cellular Therapy Archives | VJHemOnc - 3 year(s) ago
Skip to contentVisit Welcome to CAR-T & Cellular Therapy Focus, where you can explore the latest updates in this field by haematological disease and therapy type, showcasing expert interviews and discussions, podcasts and e-learning.CAR-T and other cellular therapies are at the frontier of hematological malignancy research, offering the potential for paradigm-changing new treatments. Although…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📣 The #iwCART21 session on #CART in #CLL wraps up with another insightful discussion! w/ David Porter, David Maloney, Loretta Nastoupil, Tanya Siddiqi, @drjgauthier and John Gribben 👨⚕️👩⚕️ More #CARTcell updates 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #Immunotherapy #LEUsm #CLLsm https://t.co/O6pMvtDGC3
-
David Porter of @Penn wraps up the #iwCART21 session on CAR-T in #CLL discussing when we can use the word ‘cure’ for #CLL 👨⚕️ More #CARTcell updates 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #CART #Immunotherapy #tcellrx #CellularTherapy #LEUsm #LYMsm #OncoAlert #CLLsm #Leukemia https://t.co/4x7gCMXcK6
-
Next at #iwCART21: Loretta Nastoupil of @MDAndersonNews discusses CAR NK treatments for #CLL 👩⚕️ 📣 More #CellularTherapy updates 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #CART #CARTcell #NKcells #Immunotherapy #tcellrx #HemOnc #LEUsm #LYMsm #OncoAlert #CLLsm #Leukemia https://t.co/gNuIWrJP53
-
Tanya Siddiqi of @cityofhope talks on liso-cel for #CLL at #iwCART21 👩⚕️ 📣 More #CARTcell updates 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #CART #CARTcell #Immunotherapy #tcellrx #CellularTherapy #HemOnc #LEUsm #LYMsm #OncoAlert #CLLsm #Leukemia https://t.co/kEyDxvsw75
-
#iwCART21: @drjgauthier of @frehutch discusses ibrutinib combined with CD19 CAR T-cells for #CLL 👨⚕️ 📣 More #CARTcell updates 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #CART #CARTcell #Immunotherapy #tcellrx #CellularTherapy #HemOnc #LEUsm #LYMsm #OncoAlert #CLLsm #Leukemia https://t.co/rSapf6Yqa4
-
📣 It's time for #iwCART21 Session 3: #CART in #CLL 🙌 Chaired by John Gribben and David Porter👨⚕️👨⚕️ More #CARTcell updates 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #CARTcell #Immunotherapy #tcellrx #CellularTherapy #HemOnc #LEUsm #OncoAlert #CLLsm #Leukemia https://t.co/0kB45oIeMl
-
-
Mashup Score: 7CAR-T & Cellular Therapy Archives | VJHemOnc - 3 year(s) ago
Skip to contentVisit Welcome to CAR-T & Cellular Therapy Focus, where you can explore the latest updates in this field by haematological disease and therapy type, showcasing expert interviews and discussions, podcasts and e-learning.CAR-T and other cellular therapies are at the frontier of hematological malignancy research, offering the potential for paradigm-changing new treatments. Although…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Jae Park of @sloan_kettering wraps up #iwCART21's session on CAR-T for ALL with a talk on bridging therapy and the role of HSCT after CAR-T 👨⚕️ More #CARTcell updates 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #Immunotherapy #tcellrx #CellularTherapy #LEUsm #LYMsm #ALLsm #Leukemia https://t.co/HgjLKW7egp
-
#iwCART21: @BSantomasso of @sloan_kettering shares updates on neurotoxicity 👩⚕️ More #CARTcell updates 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #CART #CARTcell #Immunotherapy #tcellrx #CellularTherapy #HemOnc #LEUsm #LYMsm #OncoAlert #ALLsm #Leukemia https://t.co/wHyIvltf0g
-
Nirali Shah of @theNCI outlines approaches to dual targeting with CAR T-cells at #iwCART21 👩⚕️ 📣 More #CARTcell updates 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #CART #Immunotherapy #tcellrx #CellularTherapy #HemOnc #LEUsm #LYMsm #OncoAlert #ALLsm #Leukemia https://t.co/LVe4pYIw6O
-
-
Mashup Score: 4CAR-T & Cellular Therapy Archives | VJHemOnc - 3 year(s) ago
Skip to contentVisit Welcome to CAR-T & Cellular Therapy Focus, where you can explore the latest updates in this field by haematological disease and therapy type, showcasing expert interviews and discussions, podcasts and e-learning.CAR-T and other cellular therapies are at the frontier of hematological malignancy research, offering the potential for paradigm-changing new treatments. Although…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Next up at #iwCART21: @drclaireroddie of @ucl talks on adult #ALL and CART19 👩⚕️ More #CARTcell updates 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #CART #Immunotherapy #tcellrx #CellularTherapy #HemOnc #LEUsm #LYMsm #OncoAlert #ALLsm #Leukemia https://t.co/dYRGsxeAnY
-
#iwCART21: Cameron Turtle of @fredhutch outlines factors associated with durable remissions after CAR-T 👨⚕️ 📣 More #CARTcell updates 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #CART #Immunotherapy #tcellrx #CellularTherapy #HemOnc #LEUsm #LYMsm #OncoAlert #ALLsm #Leukemia https://t.co/2M1CGqDqMz
-
Reuben Benjamin of @KingsCollegeNHS talks on allogeneic CAR-Ts for #ALL at the CAR-T in ALL session of #iwCART21 👨⚕️ 📣 More #CARTcell updates 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #CART #Immunotherapy #tcellrx #CellularTherapy #HemOnc #LEUsm #LYMsm #OncoAlert #ALLsm #Leukemia https://t.co/PomKtMfgMB
-
-
Mashup Score: 2CAR-T & Cellular Therapy Archives | VJHemOnc - 3 year(s) ago
Skip to contentVisit Welcome to CAR-T & Cellular Therapy Focus, where you can explore the latest updates in this field by haematological disease and therapy type, showcasing expert interviews and discussions, podcasts and e-learning.CAR-T and other cellular therapies are at the frontier of hematological malignancy research, offering the potential for paradigm-changing new treatments. Although…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📣 It's discussion time at #iwCART21 👩⚕️👨⚕️ Saar Gill, Richard Aplenc, @MSubklewe, @romeerizwan and John DiPersio are answering audience questions on #CART in #AML 🙌 More #CARTcell updates 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #Immunotherapy #CellularTherapy #AMLsm #Leukemia https://t.co/axGjySMf7z
-
Next up at #iwCART21: @MSubklewe of @LMU_Muenchen talks on CAR-T versus BiTE therapy in #AML 👩⚕️ 📣 More #CARTcell updates here 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #CART #Immunotherapy #tcellrx #CellularTherapy #HemOnc #LEUsm #LYMsm #OncoAlert #AMLsm #Leukemia https://t.co/pTHopsXKJQ
-
-
Mashup Score: 1CAR-T & Cellular Therapy Archives | VJHemOnc - 3 year(s) ago
Skip to contentVisit Welcome to CAR-T & Cellular Therapy Focus, where you can explore the latest updates in this field by haematological disease and therapy type, showcasing expert interviews and discussions, podcasts and e-learning.CAR-T and other cellular therapies are at the frontier of hematological malignancy research, offering the potential for paradigm-changing new treatments. Although…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#iwCART21: Richard Aplenc of the @CHOPCancerCntr outlines the role of CAR T-cells in pediatric #AML 👨⚕️ 📣 More #CARTcell updates 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #CART #Immunotherapy #tcellrx #CellularTherapy #HemOnc #LEUsm #LYMsm #OncoAlert #AMLsm #Leukemia https://t.co/sqIiA6lxSG
-
📣 Saar Gill of @PennMedicine kicks off the #iwCART21 session on CAR-T for #AML with a talk on clinical trials 👨⚕️ More #CARTcell updates here 👉https://t.co/72Hx68SKm0👈 @VJHemOnc #CART #Immunotherapy #tcellrx #CellularTherapy #HemOnc #LEUsm #LYMsm #OncoAlert #AMLsm #Leukemia https://t.co/FOnVwXCNQh
-
📣 Catch up on the latest updates on CAR-T therapy for #Lymphoma with our new #VJSounds podcast! With leading experts including Caron Jacobson, Stephen Schuster & Jeremy Abramson 👨⚕️👩⚕️ 🎧 Listen now: https://t.co/cERuvB4Xhn @VJHemOnc #iwCART21 #LYMsm #CART #CaxTx